Activez les alertes d’offres d’emploi par e-mail !
Mulipliez les invitations à des entretiens
Créez un CV sur mesure et personnalisé en fonction du poste pour multiplier vos chances.
A leading company is seeking a Medical Scientist for its clinical development team. This role will significantly impact clinical trials in a global setting, requiring expertise in clinical development phases I–III, particularly in GvHD and hematology. The successful candidate will play a pivotal role in ensuring scientific integrity and operational excellence throughout the trials.
Social network you want to login/join with:
col-narrow-left
i-Pharm Consulting
Other
-
Yes
col-narrow-right
292686402573828096032765
4
09.06.2025
24.07.2025
col-wide
Medical Scientist – Clinical Development (Phases I–III)
Location: Remote | Full-Time
We are seeking an enthusiastic and innovative Medical Scientist to join our clinical development team and play a leading role in advancing programs across GvHD, allo-HSCT, and haematology. This is a high-impact position reporting directly to the Head of Clinical Development and offers the opportunity to influence early to late-stage clinical trials (Phases I–III) in a fast-moving, global environment.
You will partner closely with study physicians, external research teams, and clinical operations to drive data quality, strategic planning, and innovation. Contribute to the clinical development plan with up-to-date insights into scientific and medical advances. Serve as a clinical/medical lead on study management teams, ensuring the scientific integrity of the program. Collaborate with medical staff and KOLs in hematology to align on strategy and execution. Oversee clinical trials from a medical and safety perspective, including pharmacovigilance responsibilities.
Requirements include a scientific or medical background with experience in clinical development (Phases I–III), ideally with a focus on GvHD, allo-HSCT, and hematology. Strong medical writing and clinical data analysis skills are essential. Experience interacting with clinical sites and KOLs, including participation in international scientific conferences, is also required.